IL148965A0 - Synergistic combinations of an nk1 receptor antagonists and a gaba structural analog - Google Patents

Synergistic combinations of an nk1 receptor antagonists and a gaba structural analog

Info

Publication number
IL148965A0
IL148965A0 IL14896500A IL14896500A IL148965A0 IL 148965 A0 IL148965 A0 IL 148965A0 IL 14896500 A IL14896500 A IL 14896500A IL 14896500 A IL14896500 A IL 14896500A IL 148965 A0 IL148965 A0 IL 148965A0
Authority
IL
Israel
Prior art keywords
receptor antagonists
synergistic combinations
structural analog
gaba
gaba structural
Prior art date
Application number
IL14896500A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL148965A0 publication Critical patent/IL148965A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14896500A 1999-10-07 2000-10-05 Synergistic combinations of an nk1 receptor antagonists and a gaba structural analog IL148965A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15827199P 1999-10-07 1999-10-07
PCT/EP2000/009858 WO2001024792A1 (en) 1999-10-07 2000-10-05 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog

Publications (1)

Publication Number Publication Date
IL148965A0 true IL148965A0 (en) 2002-11-10

Family

ID=22567369

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14896500A IL148965A0 (en) 1999-10-07 2000-10-05 Synergistic combinations of an nk1 receptor antagonists and a gaba structural analog

Country Status (38)

Country Link
EP (2) EP1221950B1 (da)
JP (2) JP2003510356A (da)
KR (1) KR20020060192A (da)
CN (1) CN1387434A (da)
AP (1) AP2002002501A0 (da)
AR (1) AR029646A1 (da)
AT (1) ATE269072T1 (da)
AU (2) AU7663300A (da)
BG (1) BG106548A (da)
BR (1) BR0014598A (da)
CA (1) CA2385930A1 (da)
CO (1) CO5280195A1 (da)
CR (1) CR6614A (da)
CZ (1) CZ20021116A3 (da)
DE (1) DE60011650T2 (da)
DK (1) DK1221950T3 (da)
EA (1) EA004266B1 (da)
EE (1) EE200200185A (da)
ES (1) ES2220542T3 (da)
GT (1) GT200000166A (da)
HR (1) HRP20020286A2 (da)
HU (1) HUP0203466A3 (da)
IL (1) IL148965A0 (da)
IS (1) IS6318A (da)
MA (1) MA26826A1 (da)
MX (1) MXPA02003484A (da)
NO (1) NO20021625D0 (da)
NZ (1) NZ517949A (da)
OA (1) OA12063A (da)
PA (1) PA8504301A1 (da)
PE (1) PE20010708A1 (da)
PL (1) PL357498A1 (da)
PT (1) PT1221950E (da)
SK (1) SK4542002A3 (da)
TR (1) TR200200913T2 (da)
UY (1) UY26376A1 (da)
WO (2) WO2001024792A1 (da)
ZA (1) ZA200202675B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189872B1 (pl) 1996-07-24 2005-10-31 Warner Lambert Co Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CN1662231A (zh) * 2002-04-24 2005-08-31 柏树生物科学公司 包括应激相关障碍在内的功能性躯体障碍的预防与治疗
CN1720025A (zh) * 2002-10-08 2006-01-11 兰贝克赛实验室有限公司 加巴喷丁片剂及其制备
AU2004224322A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. Methods of treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators
WO2004084881A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
US20060264509A1 (en) * 2003-03-21 2006-11-23 Fraser Matthew O Methods for treating pain using smooth muscle modulators and a2 subunit calcium channel modulators
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
DE102007019071A1 (de) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
CA2805371C (en) 2010-07-30 2017-10-31 Toray Industries, Inc. Therapeutic agent or prophylactic agent for neuropathic pain
DK2621282T3 (da) * 2010-09-28 2020-05-04 Univ California Gaba-agonister i behandlingen af forstyrrelser forbundet med metabolisk syndrom og gaba-kombinationer i behandling eller profylakse af type i diabetes
DK3946260T3 (da) * 2019-03-26 2026-03-23 Orion Corp Pregabalinformuleringer og anvendelse deraf
WO2022234110A1 (en) * 2021-05-07 2022-11-10 Plus Vitech, S.L. Gamma-aminobutyric acid derivatives for use in cancer therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
US5792796A (en) * 1994-07-27 1998-08-11 Warner-Lambert Company Methods for treating anxiety and panic
US5510381A (en) * 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
DE69736390T2 (de) * 1996-10-07 2007-07-26 Merck Sharp & Dohme Ltd., Hoddesdon Zns-penetrierende nk-1 rezeptorantagonisten als antidepressivum und / oder anxiolytikum
JP2001504848A (ja) * 1996-12-02 2001-04-10 メルク シヤープ エンド ドーム リミテツド 重症不安障害の治療のためのｎｋ−１受容体拮抗薬の使用

Also Published As

Publication number Publication date
HUP0203466A2 (hu) 2003-02-28
AR029646A1 (es) 2003-07-10
HRP20020286A2 (en) 2003-08-31
BR0014598A (pt) 2002-06-11
WO2001024792A1 (en) 2001-04-12
DE60011650T2 (de) 2005-07-14
GT200000166A (es) 2002-03-30
MXPA02003484A (es) 2004-09-10
CA2385930A1 (en) 2001-04-12
HUP0203466A3 (en) 2005-03-29
PE20010708A1 (es) 2001-07-27
AP2002002501A0 (en) 2002-06-30
DK1221950T3 (da) 2004-09-20
OA12063A (en) 2006-05-03
CO5280195A1 (es) 2003-05-30
EP1233766A1 (en) 2002-08-28
WO2001024792A9 (en) 2002-09-06
SK4542002A3 (en) 2003-09-11
EP1221950B1 (en) 2004-06-16
BG106548A (en) 2002-12-29
UY26376A1 (es) 2000-12-29
MA26826A1 (fr) 2004-12-20
JP2003510355A (ja) 2003-03-18
KR20020060192A (ko) 2002-07-16
WO2001024791A1 (en) 2001-04-12
EP1221950A1 (en) 2002-07-17
CZ20021116A3 (cs) 2003-05-14
NO20021625L (no) 2002-04-05
NO20021625D0 (no) 2002-04-05
PA8504301A1 (es) 2002-08-26
JP2003510356A (ja) 2003-03-18
ATE269072T1 (de) 2004-07-15
NZ517949A (en) 2003-08-29
CN1387434A (zh) 2002-12-25
CR6614A (es) 2003-12-04
PL357498A1 (en) 2004-07-26
AU7663300A (en) 2001-05-10
IS6318A (is) 2002-03-21
EA004266B1 (ru) 2004-02-26
TR200200913T2 (tr) 2002-09-23
DE60011650D1 (de) 2004-07-22
EA200200303A1 (ru) 2002-08-29
EE200200185A (et) 2003-04-15
ZA200202675B (en) 2003-04-15
PT1221950E (pt) 2004-08-31
AU1696201A (en) 2001-05-10
ES2220542T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
IL148965A0 (en) Synergistic combinations of an nk1 receptor antagonists and a gaba structural analog
HU9801861D0 (en) Ccr-3 receptor antagonists
AU143389S (en) A set of desks
IL136714A0 (en) Automatic injector for administrating a medicament
GB9927056D0 (en) Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
HRP980197B1 (en) GnRH ANTAGONISTS
IL130760A0 (en) Vitronectin receptor antagonists
PL341114A1 (en) Antagonists of thrombosin receptors
PL352056A1 (en) Antagonists of bradykinin receptor
PL328633A1 (en) Oxazolic and thiadizolic antagonists of muscarinic receptors
PL339381A1 (en) Antagonists of vitronectin receptor
IL128631A0 (en) Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
ZA98256B (en) Tachykinin antagonists
IL131859A0 (en) Multipart dowel for a removable anchor
GB9600344D0 (en) Benzimidzolyl neuropeptide y receptor antagonists
IL141899A0 (en) Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin
IL146085A0 (en) Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
IL150203A0 (en) Non peptide tachykinin receptor antagonists
AU140674S (en) A set of desks
GB9925195D0 (en) A dental implant anchor
GB9619583D0 (en) Compositions and methods for administering integrin receptor antagonists
TW321871U (en) A multifunctional deck/chair set
AU131614S (en) A set of towel rails
IL132647A0 (en) Modular denture
ZA9610116B (en) Heterocyclic compounds having tachykinin receptor antagonist activity their preparation and their use